CLARIANE SE (CLARI.PA) Stock Fundamental Analysis
EPA:CLARI - Euronext Paris - Matif - FR0010386334 - Common Stock - Currency: EUR
Overall CLARI gets a fundamental rating of 3 out of 10. We evaluated CLARI against 24 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of CLARI have multiple concerns. CLARI is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CLARI had negative earnings in the past year.
In the past year CLARI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLARI reported negative net income in multiple years.
CLARI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CLARI has a Return On Assets of -0.39%. This is in the lower half of the industry: CLARI underperforms 70.83% of its industry peers.
CLARI's Return On Equity of -1.49% is on the low side compared to the rest of the industry. CLARI is outperformed by 70.83% of its industry peers.
The Return On Invested Capital of CLARI (1.86%) is worse than 62.50% of its industry peers.
CLARI had an Average Return On Invested Capital over the past 3 years of 1.96%. This is below the industry average of 5.69%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.39% | ||
| ROE | -1.49% | ||
| ROIC | 1.86% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
1.3 Margins
With a Operating Margin value of 5.44%, CLARI perfoms like the industry average, outperforming 54.17% of the companies in the same industry.
In the last couple of years the Operating Margin of CLARI has declined.
CLARI's Gross Margin of 91.68% is amongst the best of the industry. CLARI outperforms 100.00% of its industry peers.
CLARI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.44% | ||
| PM (TTM) | N/A | ||
| GM | 91.68% |
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CLARI is destroying value.
CLARI has more shares outstanding than it did 1 year ago.
CLARI has more shares outstanding than it did 5 years ago.
CLARI has a better debt/assets ratio than last year.
2.2 Solvency
CLARI has an Altman-Z score of 0.62. This is a bad value and indicates that CLARI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.62, CLARI is doing worse than 62.50% of the companies in the same industry.
The Debt to FCF ratio of CLARI is 13.44, which is on the high side as it means it would take CLARI, 13.44 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CLARI (13.44) is worse than 62.50% of its industry peers.
CLARI has a Debt/Equity ratio of 1.78. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.78, CLARI is in line with its industry, outperforming 45.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.78 | ||
| Debt/FCF | 13.44 | ||
| Altman-Z | 0.62 |
ROIC/WACC0.45
WACC4.15%
2.3 Liquidity
CLARI has a Current Ratio of 0.56. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.56, CLARI is doing worse than 79.17% of the companies in the same industry.
CLARI has a Quick Ratio of 0.56. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CLARI (0.56) is worse than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.56 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 22.18% over the past year.
Looking at the last year, CLARI shows a small growth in Revenue. The Revenue has grown by 5.73% in the last year.
The Revenue has been growing slightly by 7.89% on average over the past years.
EPS 1Y (TTM)22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.24%
Revenue 1Y (TTM)5.73%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%4.4%
3.2 Future
CLARI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.62% yearly.
The Revenue is expected to grow by 5.11% on average over the next years.
EPS Next Y157.21%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPS Next 5YN/A
Revenue Next Year4.6%
Revenue Next 2Y4.82%
Revenue Next 3Y5.11%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CLARI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 27.98, the valuation of CLARI can be described as expensive.
CLARI's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CLARI is more expensive than 62.50% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CLARI to the average of the S&P500 Index (20.49), we can say CLARI is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 27.98 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CLARI is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CLARI is valued cheaper than 91.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.36 | ||
| EV/EBITDA | 8.84 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLARI's earnings are expected to grow with 64.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y90.37%
EPS Next 3Y64.62%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 10.64%, CLARI is a good candidate for dividend investing.
CLARI's Dividend Yield is rather good when compared to the industry average which is at 2.71. CLARI pays more dividend than 100.00% of the companies in the same industry.
CLARI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
5.2 History
The dividend of CLARI decreases each year by -5.96%.
Dividend Growth(5Y)-5.96%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of CLARI are negative and hence is the payout ratio. CLARI will probably not be able to sustain this dividend level.
DP-92.12%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPA:CLARI (5/2/2025, 5:00:37 PM)
3.92
+0.2 (+5.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners41.38%
Inst Owner ChangeN/A
Ins Owners5.63%
Ins Owner ChangeN/A
Market Cap1.40B
Analysts45.45
Price Target2.79 (-28.83%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
Yearly Dividend0.21
Dividend Growth(5Y)-5.96%
DP-92.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)52.9%
PT rev (3m)52.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.64%
EPS NY rev (3m)440%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.45%
Revenue NY rev (3m)0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 27.98 | ||
| P/S | 0.26 | ||
| P/FCF | 2.36 | ||
| P/OCF | 1.55 | ||
| P/B | 0.38 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.84 |
EPS(TTM)-0.47
EYN/A
EPS(NY)0.14
Fwd EY3.57%
FCF(TTM)1.66
FCFY42.42%
OCF(TTM)2.53
OCFY64.49%
SpS14.84
BVpS10.37
TBVpS-5.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.39% | ||
| ROE | -1.49% | ||
| ROCE | 2.53% | ||
| ROIC | 1.86% | ||
| ROICexc | 1.95% | ||
| ROICexgc | 4.01% | ||
| OM | 5.44% | ||
| PM (TTM) | N/A | ||
| GM | 91.68% | ||
| FCFM | 11.21% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
ROICexc(3y)2.07%
ROICexc(5y)2.22%
ROICexgc(3y)4.16%
ROICexgc(5y)4.53%
ROCE(3y)2.66%
ROCE(5y)2.78%
ROICexcg growth 3Y-9.02%
ROICexcg growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score5
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.78 | ||
| Debt/FCF | 13.44 | ||
| Debt/EBITDA | 6.65 | ||
| Cap/Depr | 43.77% | ||
| Cap/Sales | 5.83% | ||
| Interest Coverage | 0.96 | ||
| Cash Conversion | 90.82% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 0.62 |
F-Score5
WACC4.15%
ROIC/WACC0.45
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.24%
EPS Next Y157.21%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPS Next 5YN/A
Revenue 1Y (TTM)5.73%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%4.4%
Revenue Next Year4.6%
Revenue Next 2Y4.82%
Revenue Next 3Y5.11%
Revenue Next 5YN/A
EBIT growth 1Y-8.92%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year311.97%
EBIT Next 3Y70.36%
EBIT Next 5YN/A
FCF growth 1Y85%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.93%
OCF growth 3Y2.33%
OCF growth 5Y3.29%